Hunan Jiudian Pharmaceutical (300705.SZ): Two products obtained drug registration certificates.
Jiudian Pharmaceutical (300705.SZ) announced that the company recently received the "Drug Registration Certificate" issued by the National Medical Products Administration, involving the products: "Nifedipine Tablets" and "Ambroxol Hydrochloride Oral Solution".
Hunan Jiudian Pharmaceutical (300705.SZ) announced that the company has recently received the "Drug Registration Certificate" issued by the National Medical Products Administration, involving products: "Nifedipine tablets" and "Ambroxol Hydrochloride oral solution".
Related Articles
Shareholder Ningbo Sihui of Ananda Drive Techniques (Shanghai) Co., Ltd. (603350.SH) plans to reduce its shareholding by no more than 3%.
JL Mag Rare-Earth (06680) is pleased to announce that it is expected to achieve a consolidated net profit attributable to the owners of the company of 400 million to 460 million yuan in the first half of the year, representing a year-on-year increase of 31.17% to 50.84%.
CA CULTURAL (01566) released its annual performance, with shareholders' net loss of HKD 99.938 million, an increase of 202.45% year-on-year.
Shareholder Ningbo Sihui of Ananda Drive Techniques (Shanghai) Co., Ltd. (603350.SH) plans to reduce its shareholding by no more than 3%.
JL Mag Rare-Earth (06680) is pleased to announce that it is expected to achieve a consolidated net profit attributable to the owners of the company of 400 million to 460 million yuan in the first half of the year, representing a year-on-year increase of 31.17% to 50.84%.
CA CULTURAL (01566) released its annual performance, with shareholders' net loss of HKD 99.938 million, an increase of 202.45% year-on-year.
RECOMMEND
